Sumitomo Mitsui Trust Holdings, Inc. Standard Biotools Inc. Transaction History
Sumitomo Mitsui Trust Holdings, Inc.
- $134 Billion
- Q2 2024
A detailed history of Sumitomo Mitsui Trust Holdings, Inc. transactions in Standard Biotools Inc. stock. As of the latest transaction made, Sumitomo Mitsui Trust Holdings, Inc. holds 10,642,271 shares of LAB stock, worth $22.6 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
10,642,271
Previous 8,853,491
20.2%
Holding current value
$22.6 Million
Previous $24 Million
21.49%
% of portfolio
0.01%
Previous 0.02%
Shares
2 transactions
Others Institutions Holding LAB
# of Institutions
148Shares Held
269MCall Options Held
422KPut Options Held
40.7K-
Casdin Capital, LLC New York, NY64MShares$136 Million9.8% of portfolio
-
Viking Global Investors LP58.7MShares$124 Million0.41% of portfolio
-
Black Rock Inc. New York, NY21.8MShares$46.1 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA16MShares$33.9 Million0.0% of portfolio
-
Morgan Stanley New York, NY12.9MShares$27.4 Million0.0% of portfolio
About STANDARD BIOTOOLS INC.
- Ticker LAB
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 78,654,800
- Market Cap $167M
- Description
- Standard BioTools Inc. creates, manufactures, and markets instruments, consumables, reagents, and software for researchers and clinical laboratories worldwide. It offers analytical systems, such as Helios, a CyTOF system, as well as Hyperion imaging systems, Hyperion tissue imagers, and flow conductors; and assays and reagents, including Maxpar ...